Connect with us

Medical

Can Hemp Oil Treat Epilepsy in Dogs?

Published

on

hemp oil for dogs

A research suggests that hemp oil is good for reducing epilepsy in dogs. It has the same effects as the medicine epidiolex which is a CBD based drug. People who actively use CBD agree to the fact that it has helped them in alleviating many issues regarding their health problems. They range from chronic pains of almost any type to insomnia. The benefits of the substance are not only limited to humans, but also to humans’ best friends: dogs. CBD is highly trendy among pet owners as it has been quite beneficial in treating certain conditions like pain and canine anxiety. However, experts say that there is a need to o more research before giving CBD directly to pet dogs.

They noted a considerable reduction in the epileptic seizures among the experimental group

The study consisted of 16 pets having epilepsy. Canine epilepsy is a common condition that effects 5% dogs. The Canine Health Foundation suggested that there is a need for innovative therapeutic substances for dealing with the disease. Out of the total, scientists dosed nine dogs with the CBD. The remaining seven were in the control group and given placebo. They found that CBD administration reduced the chances of the typical seizure up to 89 percent. The study opens up a possibility for researchers to dive further into its benefits and make the products commercially available.

Researches like these need to be conducted on a much wider scale to investigate proper results

However, there are some points of consideration regarding the study. Firstly, the results were observed for only 16 dogs. Secondly, Applied Basic Science Corporation sponsored the study that is itself a manufacturer in this emerging industry. The scientist leading the research has a 5 percent stake in the brand. There is a hope to see the same results on a wider subject ratio.

Scientists have conducted multiple small studies on the effects of CBD on dogs

In addition to that, the effects of CBD are also investigated regarding osteoarthritis, another common bone condition among dogs. This study took place in 2018 and researchers used 14 dogs. However, the most important thing, safety, is not put under notice yet. Moreover, Food and Drug Administration in US has not officially passed approval of CBD for dogs. They haven’t designed a chart for dosage.

Veterinary doctors suggest that pet owners must be considerate on choosing potential therapeutic options while treating their dogs. Despite the fact that marijuana does not involve any potential harming effects on overdose, it must not be applied for animals. In addition, hemp oil can be easily handled by anyone and its regulated administration goes unnoticed that can be damaging.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

New Technology to Predict Cancer Recurrence in Melanoma Patients

Published

on

The beginning of melanoma takes place when a small pigmented spot appears on the skin. By removing the lesion, a primary melanoma can be treated but it has a tendency of reoccurrence and can spread throughout the body. A new study showed that the likelihood of cancer can be predicted after the removal of the lesion.

Despite all medical advancements, the analysis of lesion his performed in the same old way. Generally, molecular diagnostic labs have many advances for the detection of other forms of cancer but for the skin lesion cancer the way of diagnosis is very simple. The diagnosis is based on the thickness of the melanoma and microscopic features.

A patient with thinner melanomas is considered to be normal and the T stage from 1 to 4 is assigned. The complete details of this study are published in Nature Cancer.

Read more- First Pneumonia Related Death Reported in China

The researchers from the Brigham and Women’s Hospital in collaboration with international colleagues showed a new technique about the reoccurrence and spread of melanomas. It leverages the sequences of DNA for predicting the possible factors involved in the reoccurrence and spread of melanomas.

Thomas Kupper who is the chairperson of the department of dermatology at the Brigham that there were no treatments available for metastatic melanoma 10 years ago. But now it is possible to treat the patients who have metastatic melanoma and these treatments can be given at the primary stage of the disease. It is important to have a clear idea about the patient’s progress report after giving the new immunotherapy treatments, so we can modify the treatment.

There are immune checkpoint inhibitors that can reinitiate the immune response through T cell against the cancer cells. These inhibitors have changed the results and options for the patients in which cancer has spread throughout the body. Immune checkpoint inhibitors can start dramatic responses such as long-term remission in the period of curing a patient.

Read more- Global Alliance for Cannabis Commerce announces GACC Certified™ testing

Kupper and colleagues wanted to know about some measurable features of T cells. These features are used to check the predictions of the reoccurrence of melanoma in the removed primary melanoma and disease-free patients. Scientists study T2, T2, and T4 primary melanoma as the T1 are rarely metastasized melanoma.

They also face difficulty in finding the sample that was enough for results because skin lesion surgeries are usually performed at private clinics and ambulatory clinics. So, the concentration of the specimen is not available in the hospitals. For resolving this issue and for sharing the resources researchers collaborated with colleagues of the Melanoma Institute of Australia and the Zealand university Hospital in Denmark. The sample size for the analysis contains more than 300 patients from different areas.

The samples of primary melanoma patients with progress have been compared with those patients whose primary melanoma did not show any progress. For analyzing the T cell range of tumors, Adaptive Biotechnologies performed high throughput DNA sequencing. It was found that out of all identified variables the T cell fraction (TCFr) was an independent and strong predictor for the patients’ progress condition.

Patients with the same lesion thickness were more at the risk of developing metastatic disease. If the TCFr value is lower than 20 % in the patients, then they are more at the risk of disease progression. On the other hand, if the TCFr value is more than 20% then the risk of disease progression is low in patients.

Read more- Dangerous Effects of Cannabis During Pregnancy Explained by New Research

 The test used in this study is not available at the commercial level for clinical use. It is only used for research purposes. The authors said that the study is retrospective because it took the sample and data of patients that are already available. While the prospective study is that in which data for outcomes is not known and further tests are needed for validation.

Kupper and colleagues imagine that if a test could bring to the clinics then it will improve the patient care and strengthen the results. The test is elegant, simple and quantitative. These types of tests will help us in the future to modify the treatments according to the situation. If the patients have high TCFr then we will benefit him with checkpoint inhibitor therapy. If the value is low in patients, then more interventions are needed.

 

Continue Reading

General News

Dangerous Effects of Cannabis During Pregnancy Explained by New Research

Published

on

Cannabis is a derivative of Cannabis sativa that affects the normal functioning of the brain and impairs motor coordination leading to hallucinating effect. This new study suggests that cannabis exposure has real-time devastating effects on the fetus and placental development during the gestation period in pregnancy.

The principal constituent in cannabis is Tetrahydrocannabinol (THC) and the researchers at Western University and Queens University find that regular exposure to THC has a great effect on the development of the placenta and fetus during gestation. Since recreational cannabis has been legalized in Canada, the effects of cannabis during pregnancy are beginning to be perceived.

This study published in Nature’s Scientific Reports and it is available online.

Researchers used a rat model and human placental cells to show that regular exposure to THC during pregnancy has a great impact on not only the development of the vital organs of the fetus but also on the gene expression that is extremely important for the proper functioning of the placenta.

Read more- First Pneumonia Related Death Reported in China

The researchers practically find an 8 percent deduction in birth weight and diminished growth of brain and liver by more than 20 percent during gestation in a rat model due to the regular exposure to a low-dose of THC that copies the daily use of cannabis.

An associate professor, Daniel B. Hardy at Westerns Schulich School of Medicine and Dentistry and co-author on the paper suggests that the use of cannabis during pregnancy is highly linked with low birth weight babies.

Clinical data is hard to analyze because it is perplexed by other factors. The study is a definite way that supports that THC has a direct influence on the growth of the placenta and fetus.

Oxygen and nutrients cross the placenta into the developing fetus for nourishment and the research team characterizes how THC prevents oxygen and nutrients from crossing the placenta.

Read more- Global Alliance for Cannabis Commerce announces GACC Certified™ testing

A decrease in a glucose transporter called GLUT-1 is caused by the exposure to THC that was found by studying the placental cells of humans. This shows that THC is stopping the transfer of key nutrient glucose through the placenta, from mother to the fetus. A reduction in placental vasculature was also found in the rat model and infers a reduced flow of blood from the mother to the fetus.

In the researcher’s opinion the restricted growth they observed in the offspring is likely caused by both of these factors and find that there are recently no proper guidelines from Health Canada on the use of cannabis during the gestation period.

To prevent morning sickness, for anxiety, depression or social issues up to one in five women are using cannabis during pregnancy according to some studies.

A Ph.D.,  Associate Professor, David Natale at Queens finds in Canada and many states of the US the use of marijuana has been legalized, but its use during gestation period has not been studied well. There are very real devastating risks associated with the regular exposure of cannabis during pregnancy.

 

 

Continue Reading

Medical

NuggMD offered Free camp to Veterans for Medical Marijuana Assessment

Published

on

NuggMD, the nation’s leading cannabis market for telemedicine provided free online medical marijuana tests to Oklahoma’s veterans on Monday, 11th Nov. This service was accessible by showing a valid ID as a proof of service.

The Chief Marketing Officer and Co-Founder of NuggMD Alex Milligan said “None of us would enjoy the freedom and prosperity that we do today without our brave veterans. We are offering completely free medical marijuana evaluations to Oklahoma’s veterans this Monday in humble thanks for their service and sacrifice.”

Since the launch in 2016, NuggMD’s affiliated physicians have provided medical marijuana evaluations to nearly half a million patients in California, Nevada and New York. NuggMD officially launched in Oklahoma in 2019 and they are soon planning to expand nationwide.

Co-Founder Kam Babazade said: “The past seven weeks in Oklahoma have been amazing, response to our telemedicine services have far exceeded our expectations, and we’re very excited to see what 2020 will bring for the Midwest.”

Patients can complete the evaluation process with their new physician from home by using NuggMD’s video-enabled telemedicine platform. The evaluations are made easy for disabled or patients who are unable to travel by providing live chat feature. The evaluation can be done through the patient’s smartphone or computer.

NuggMD is the country’s top medical cannabis technology programme. They encourage access to doctors who give medicinal cannabis assessments in California, New York, Nevada and Oklahoma. NuggMD’s patients get their cannabis assessments totally online from the protection and solace of their own home. Since 2016, NuggMD has helped about a large portion of a million medical cannabis patients with the assessment procedure, advancing their main goal to improve personal satisfaction through cannabis.

Continue Reading

Trending